|

Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.

RECRUITINGSponsored by University of Thessaly
Actively Recruiting
SponsorUniversity of Thessaly
Started2024-01-12
Est. completion2026-01-11
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06958016

Summary

The aim of this study is to measure the levels of serum tryptase and correlate them with the severity of coronary artery disease in study population. In addition, it will evaluate the usability of tryptase levels as a prognostic biomarker for future cardiovascular events.

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* Male and female subjects aged 18 - 85 years old.
* Clinical symptoms of angina which are classified based on the Canadian Cardiovascular Score (CCS score)
* Positive SPECT scan for myocardial ischemia

Exclusion Criteria:

* Acute Coronary Syndrome 4 weeks before the coronary catheterization
* Percutaneous Coronary Angioplasty
* Coronary Artery Bypass Graft
* Active symptoms of allergy (asthma, urticaria)
* Mastocytosis
* Hypereosinophilia
* Autoimmune disease
* Cancer
* Kidney failure
* Myelodysplastic Syndrome
* Denial of signing informed consent

Conditions2

Chronic Coronary SyndromeHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.